OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-14.04%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$324M
AUM Growth
+$324M
Cap. Flow
-$5.02M
Cap. Flow %
-1.55%
Top 10 Hldgs %
96.16%
Holding
15
New
–
Increased
2
Reduced
2
Closed
1

Top Buys

1
EPIX icon
ESSA Pharma
EPIX
$2.11M
2
CDTX icon
Cidara Therapeutics
CDTX
$263K

Top Sells

1
GOSS icon
Gossamer Bio
GOSS
$6.72M
2
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
$660K
3
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
$12.7K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GOSS icon
1
Gossamer Bio
GOSS
$562M
$110M 33.96% 6,553,116 -400,300 -6% -$6.72M
REPL icon
2
Replimune Group
REPL
$422M
$70.7M 21.82% 5,103,455 – –
MORF
3
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$53.8M 16.6% 2,969,582 – –
TBIO
4
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$24.2M 7.46% 2,437,603 – –
IMUX icon
5
Immunic
IMUX
$80.9M
$13.7M 4.23% 1,371,494 – –
PRTK
6
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$11.2M 3.47% 2,600,410 – –
OBSV
7
DELISTED
ObsEva SA Ordinary Shares
OBSV
$8.33M 2.57% 999,364 – –
PRVL
8
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$8.21M 2.54% 668,908 – –
EPIX icon
9
ESSA Pharma
EPIX
$11.4M
$5.76M 1.78% 1,709,848 +625,000 +58% +$2.11M
TRVI icon
10
Trevi Therapeutics
TRVI
$883M
$5.69M 1.75% 1,263,408 – –
FGEN icon
11
FibroGen
FGEN
$47.8M
$4.83M 1.49% 130,646 – –
CDTX icon
12
Cidara Therapeutics
CDTX
$1.66B
$3.27M 1.01% 1,640,514 +131,720 +9% +$263K
PVLA
13
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$2.56M 0.79% 750,741 -3,716 -0.5% -$12.7K
JNCE
14
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.77M 0.54% 529,965 – –
SNNA
15
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
– – -758,610 Closed -$660K